Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, February 26, 2020
[ Wed, Feb 26th 2020
] - WOPRAI
[ Wed, Feb 26th 2020
] - WOPRAI
Tue, February 25, 2020
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
[ Tue, Feb 25th 2020
] - WOPRAI
Matt OBrien Maintained (TNDM) at Buy with Increased Target to $90 on, Feb 25th, 2020
Matt OBrien of Piper Sandler, Maintained "Tandem Diabetes Care, Inc." (TNDM) at Buy with Increased Target from $70 to $90 on, Feb 25th, 2020.
Matt has made no other calls on TNDM in the last 4 months.
There is 1 other peer that has a rating on TNDM. Out of the 1 peers that are also analyzing TNDM, all agrees with Matt's Rating of Hold. Following is the relevant analyst calls for the last 4 months
- Jeff Johnson of "Baird" Downgraded from Buy to Hold and Increased Target to $75 on, Tuesday, February 4th, 2020
